Back

Delayed diagnosis of amyloidosis: what if the patient does not have heart failure?

28 August 2018 (13:05 - 13:17)
Organised by:
Congress Presentation Part of: Amyloidosis beyond heart failure: paving the way for an early diagnosis Chronic Heart Failure, Other ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Martha Grogan

Mayo Clinic, Rochester (United States of America)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction - Amyloidosis beyond heart failure: paving the way for an early diagnosis.
Doctor M. Grogan (Rochester, US)
Presentation thumbnail
Managing amyloidosis in cardiology practice: a call for collaboration.
Doctor M. Maurer (New York, US)
Presentation thumbnail
The emerging treatment landscape in ATTR amyloidosis: what’s on the horizon?
Professor C. Rapezzi (Ferrara, IT)
Presentation thumbnail
Panel discussion and question and answer session - Amyloidosis beyond heart failure: paving the way for an early diagnosis.
Doctor M. Grogan (Rochester, US)

Access the full session

Session thumbnail
Amyloidosis beyond heart failure: paving the way for an early diagnosis

The Event

Event poster

ESC Congress 2018

28 August 2018 13:05 CET
You may be interested in
thumbnail
Congress Session
Amyloidosis - it never comes alone?
18 May 2025
thumbnail
Congress Presentation
Patients with transthyretin amyloid cardiomyopathy may have preserved, mildly reduced, or reduced ejection fraction
27 August 2021
thumbnail
Congress Presentation
Clinical characteristics and factors associated with heart failure and its influence on in-hospital mortality among hospitalized patients with amyloidosis: A national cohort study
22 May 2023
thumbnail
Congress Session
Heart failure is the stage and amyloid a key player
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources